MSCI Nordic Countries Index Slips 0.1% to 396.11; Coloplast Drops 3.9%

A flat headline index masking a concentrated drag: the weakness sits in healthcare and, more specifically, in a single name, so the sector read is doing less work than Coloplast's move itself. That distinction matters for anyone tracking Nordic exposure, since broad index stability can coexist with sharp single-stock dispersion. Whether Coloplast's decline proves idiosyncratic or the start of a wider healthcare re-rating is the open question.